1. Home
  2. Browse Decisions
  3. F.Supp.2d
  4. 538 F.Supp.2d
  5. 538 F.Supp.2d 621 (2008)
 

IN RE PFIZER, INC. SECURITIES LITIGATION

No. 06 Civ. 14199(LAK).

538 F.Supp.2d 621 (2008)

In re PFIZER, INC. SECURITIES LITIGATION. This Document Relates to: All Cases.

United States District Court, S.D. New York.

February 28, 2008.

Attorney(s) appearing for the Case

Samuel P. Sporn, Joel P. Laitman, Christopher Lometti, Jay P. Saltzman, Kurt Hunciker, Frank R. Schirripa, Daniel B. Rehns, Schoengold Sporn Laitman & Lometti, P.C., for Plaintiffs.

Dennis J. Block, Gregory A. Markel, Martin L. Seidel, Mollie E. O'Rourke, Cadwalader, Wickersham & Taft LLP, for Defendants.

MEMORANDUM OPINION

LEWIS A. KAPLAN, District Judge.

On December 2, 2006, Pfizer, Inc. ("Pfizer") announced that it was halting clinical trials of the developmental drug torcetrapib.1 By the close of the next trading day, the price of Pfizer common stock had declined by 10.62 percent.2 Plaintiffs then brought a class action against Pfizer and three of its current and former officers and directors ...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases